Effects of porcine pancreastatin on postprandial pancreatic exocrine secretion and endocrine functions in the conscious rat.
The inhibitory effect of a newly discovered polypeptide, pancreastatin, on postprandial pancreatic exocrine secretions and endocrine functions was examined in the conscious rat with a chronic external bile, pancreatic and gastric fistula. The infusion of 100 and 200 pmol/kg/h of pancreastatin significantly inhibited meal-stimulated pancreatic secretion of fluid and protein but not bicarbonate in a dose-dependent manner. The infusion of 100 and 200 pmol/kg/h of pancreastatin increased plasma pancreastatin concentrations (mean +/- SE) up to 133.5 +/- 15.9 and 209.8 +/- 14.5 pM, respectively. However, the same doses of pancreastatin failed to inhibit postprandial insulin and gastrin releases and did not affect blood glucose levels. It is suggested that pancreastatin may be an inhibitor of postprandial pancreatic exocrine secretion. However, the doses used in the present study may not have been high enough to affect endocrine functions.
Miyasaka
K
K
First Laboratory of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology, Japan.
Funakoshi
A
A
Nakamura
R
R
Kitani
K
K
Shimizu
F
F
Tatemoto
K
K
D000818:Animals; D053379:Chromogranin A; D003243:Consciousness; D004305:Dose-Response Relationship, Drug; D004435:Eating; D005746:Gastric Emptying / Q000187:drug effects; D007262:Infusions, Intravenous; D008297:Male; D010179:Pancreas / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D010187:Pancreatic Hormones / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D010189:Pancreatic Juice / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains
D053379:Chromogranin A; D010187:Pancreatic Hormones; C050836:pancreastatin